Home/Filings/4/0001615186-18-000008
4//SEC Filing

McCall Thomas D 4

Accession 0001615186-18-000008

CIK 0000883984other

Filed

Aug 26, 8:00 PM ET

Accepted

Aug 27, 3:22 PM ET

Size

26.0 KB

Accession

0001615186-18-000008

Insider Transaction Report

Form 4
Period: 2018-08-23
Transactions
  • Exercise of In-Money

    Common Stock

    2018-08-23$58.79/sh+827$48,6193,018 total
  • Exercise of In-Money

    Common Stock

    2018-08-23$60.40/sh+209$12,6242,191 total
  • Exercise of In-Money

    Non-Qualified Stock Option (right to buy)

    2018-08-235630 total
    Exercise: $61.76Exp: 2023-02-06Common Stock (563 underlying)
  • Sale

    Common Stock

    2018-08-23$300.34/sh1,599$480,2441,419 total
  • Exercise of In-Money

    Common Stock

    2018-08-24$58.79/sh+2,142$125,92811,725 total
  • Exercise of In-Money

    Non-Qualified Stock Option (right to buy)

    2018-08-247,3920 total
    Exercise: $88.76Exp: 2025-02-11Common Stock (7,392 underlying)
  • Sale

    Common Stock

    2018-08-24$303.45/sh2,901$880,3082,191 total
  • Exercise of In-Money

    Common Stock

    2018-08-24$88.76/sh+7,392$656,1149,583 total
  • Exercise of In-Money

    Non-Qualified Stock Option (right to buy)

    2018-08-238272,142 total
    Exercise: $58.79Exp: 2024-02-24Common Stock (827 underlying)
  • Exercise of In-Money

    Non-Qualified Stock Option (right to buy)

    2018-08-232090 total
    Exercise: $60.40Exp: 2022-10-11Common Stock (209 underlying)
  • Exercise of In-Money

    Common Stock

    2018-08-23$61.76/sh+563$34,7711,982 total
  • Sale

    Common Stock

    2018-08-24$302.70/sh6,633$2,007,8095,092 total
  • Exercise of In-Money

    Non-Qualified Stock Option (right to buy)

    2018-08-242,1420 total
    Exercise: $58.79Exp: 2024-02-24Common Stock (2,142 underlying)
Footnotes (5)
  • [F1]The price recorded in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $300.00 to $301.00, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
  • [F2]The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $302.35 to $303.30, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
  • [F3]The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $303.38 to $303.65, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
  • [F4]Options vest and are exercisable as to 25% of the underlying grant one year after the date of grant and in equal monthly installments thereafter for three additional years.
  • [F5]Options exercisable one-third annually over the first three anniversaries of the grant date.

Issuer

ICU MEDICAL INC/DE

CIK 0000883984

Entity typeother

Related Parties

1
  • filerCIK 0001615186

Filing Metadata

Form type
4
Filed
Aug 26, 8:00 PM ET
Accepted
Aug 27, 3:22 PM ET
Size
26.0 KB